The life science industry in Asia Pacific (APAC) countries presents a plethora of opportunities for businesses that are looking for growth in the region. However, regulatory approvals are a challenge for organizations in the APAC region.

Lack of clarity on regulatory norms is a huge hurdle before companies. Each country in Asia has its own regulatory architecture and seldom do the guidelines give a clear picture of the requirements and the processes.

BioSpectrum speaks to industry insiders and regulatory professionals, who have been spearheading the approval processes in their respective countries, in order to compile a guide on the regulatory processes in several APAC nations, including China, Taiwan, Australia, Hong Kong, India, Indonesia, Singapore and Korea.

Continue to read this section for a better picture of the regulatory requirements in the afore-mentioned APAC countries this week.